Revian Announces Patent License Agreement with GetHairMD
GetHairMD to utilize technology for In Clinic Laser applications
Morrisville, N.C., July 11, 2024 – REVIAN Inc., an aesthetic medical technology company using precise wavelengths of LED light to rejuvenate hair and skin, today announced a worldwide, royalty-bearing, patent sublicense agreement with GetHairMD, LLC (“GetHairMD”). The agreement provides GetHairMD with the exclusive rights to use our patented technology for in office or in clinic light-based hair loss solution devices.
“GetHairMD and its Clinical Advisory Board is building a unique medical grade offering that provides a full range of “best-in-class’ products and treatment options for its network of exclusive doctors to address a substantial need for patients struggling with hair loss. Paul Herchman, CEO of GetHairMD, has a long, successful track in medical aesthetics and we are proud to partner with Paul and his team.” stated John Oakley, Chief Executive Officer of Revian. “Revian’s patent portfolio is fundamental to light-based hair regeneration products and this agreement with GetHairMD is an important step in our patent licensing program demonstrating the importance of this patent portfolio in the industry.”
“We are excited to enter this exclusive agreement with Revian,” said Paul Herchman, Chief Executive Officer of GetHairMD. “GetHairMD will utilize access to Revian’s patented industry leading technology to develop and manufacture a highly efficacious in office device to treat hair-loss. This will provide our growing network of physician partners with unique and protected products.”
About the Revian Red Hair Growth System
The award-winning REVIAN RED System is an FDA-cleared, lightweight wireless cap controlled by a mobile App that functions to provide a hair loss treatment for men and women using precision LED light. The device’s patented dual wavelength LED technology provides broader scalp coverage and better skin penetration than red lasers traditionally used in low-level light therapy (LLLT) producing the best clinical trial performance of any hair rejuvenation treatment available on the market. REVIAN RED uses a patented combination of two wavelengths of LED light to stimulate the production and release of nitric oxide, proven to increase local blood flow, reduce inflammation, and inhibit DHT production which provides the right environment for new hair growth. REVIAN RED’s cleared indication for use is the treatment of androgenetic alopecia, to promote hair growth in males who have Norwood-Hamilton classifications of IIa-V patterns of hair loss and to treat androgenetic alopecia and promote hair growth in females who have Ludwig-Savin Scale I-1 to II-4, II1, II2 or frontal patterns of hair loss; both with Fitzpatrick Skin Types I-IV.
About Revian, Inc.
Revian, an operating subsidiary of KNOW Bio, LLC, is an aesthetic medical technology innovator dedicated to stimulating the body’s natural processes to rejuvenate hair and skin with light. The company creates products that precisely deliver light and allow people to experience its regenerative potential in the convenience of their own homes. Revian is committed to partnering with health-care providers and other caring professionals to deliver meaningful results, backed by scientific data. For more information, visit www.revian.com.
Contact:
John Oakley
REVIAN, Inc.
joakley@revian.com
